海藻酸钠-壳聚糖微胶囊膜强度的研究

以乳化/内部凝胶化法制备了海藻酸钠-壳聚糖微胶囊,重点考察了成膜反应过程中影响微胶囊膜强度的几个主要参数,实验发现,壳聚糖分子量低于100000,成膜反应时间高于15min,壳聚糖溶液pH值在6.0左右时制备的微胶囊膜强度较高.初步探讨了海藻酸钠与壳聚糖两种高分子发生聚电解质络合反应的机制.     

肽类药物口服剂型材料及控制释放性能研究Ⅰ.壳聚糖─海藻酸盐微囊对胰岛素的控释作用

应用壳聚糖-海藻酸盐微囊技术制备了一系列胰岛素微囊，并研究了不同反应条件如海藻酸钠浓度、壳聚糖浓度、壳聚糖分子量及壳聚糖溶液pH值对微囊的胰岛素包封率及其释放性能的影响。结果表明，海藻酸钠浓度越高，微囊对胰岛素的包封率越高，在模拟小肠液中释放速率越低；壳聚糖浓度越大，微囊的胰岛素包封率及其在模拟胃液中释放率越高，在模拟肠液中释放达最大值所需时间越长；而随壳聚糖分子量减小，微囊在胃液中释放率增高；壳聚糖溶液pH值的变化对微囊的胰岛素包封率未造成明显影响。     

单分散壳聚糖微囊的制备与表征

对水溶性壳聚糖和对苯二甲醛在水/油界面发生的交联反应进行了研究,考察了水相溶液的pH值和油相中对苯二甲醛的浓度对该界面交联反应的影响.采用微流控技术制备得到了单分散的壳聚糖微囊:首先通过毛细管同轴聚焦流微流控装置制备得到单分散的O/W/O乳液.乳液制备中,以Pluronic F-127作为水相乳化剂,羟乙基纤维素作为水相增稠剂,水溶性壳聚糖溶于中间水相;交联剂对苯二甲醛溶于内部油相;含乳化剂PGPR 90的大豆油作为外部油相.乳液制备完成后,以乳液为模板,对苯二甲醛通过油/水界面扩散进入水层,与壳聚糖的氨基发生交联反应,生成壳聚糖聚合物凝胶网络,从而构成微囊的囊壁.通过光学显微镜分析和扫描电镜观察发现:微囊具备良好的单分散性和球形度以及尺寸均一的内部空腔,微囊的囊壁致密无孔.所得单分散微囊在药物传递等领域具备潜在的应用价值.     

海藻酸钙-壳聚糖微胶囊组成对BSA通透性能影响的研究

对海藻酸钙-壳聚糖微胶囊的牛血清白蛋白(BSA)双向通透性能进行了定量和定性的初步研究, 并初步考察了微胶囊的组成成分及海藻酸钠、壳聚糖的溶液浓度对BSA通透性能的影响. 结果表明海藻酸钙-壳聚糖微胶囊在pH 1.5～2.0时通透性减弱, pH 6.8时通透性增强, 且海藻酸钙微胶囊通透性大于海藻酸钙-壳聚糖微胶囊; 海藻酸钙-壳聚糖微胶囊中壳聚糖浓度越小, 通透性越好; 海藻酸钠浓度的影响不显著.     

海藻酸钠-壳聚糖微胶囊作为肠道内生化微反应器的研究

基因工程技术的发展使蛋白、多肽类高值生化药物的大规模生产得以实现并用于临床^[1].但目前存在产物分离、纯化工艺复杂、成本高等问题.因此,研制一种无需分离纯化、低成本的肠道内生化微反应器作为基因工程药物释放系统具有实际应用意义(例如将基因工程微生物包埋在具有半透性高分子膜的微胶囊中,口服后微囊化活细胞在肠道内生长并分泌有治疗作用的基因工程药物而达到治疗目的^[2]).本文以酵母菌Pichia pastoris GS115为模型菌株,以海藻酸钠-壳聚糖(A lginate-chitosan,AC)微胶囊为载体,考察了AC微囊化酵母菌在模拟胃肠液中的形态、膨胀性能、酵母菌存活率及小鼠口服后肠道黏膜粘附性能,初步证明AC微囊化基因工程酵母菌作为肠道生化微反应器是可行的.     

壳聚糖超声可控降解及降解动力学研究

通过正交实验法考察了壳聚糖溶液浓度、反应温度、超声强度以及醋酸溶液浓度对超声降解反应的影响,确定了最佳反应条件,制备了一系列不同分子量的壳聚糖.研究了壳聚糖溶液浓度、反应温度以及壳聚糖原料分子参数与降解速率常数的关系.通过红外光谱、X-射线衍射和凝胶渗透色谱对降解产物进行了表征.结果表明,超声降解壳聚糖的最佳条件为10℃,壳聚糖溶液浓度2.5g/L.降解速率常数随壳聚糖溶液浓度和反应温度的降低而增大.高分子量和低脱乙酰度的壳聚糖原料有较高的降解速率和降解速率常数,壳聚糖原料的分子量对降解速率和降解速率常数的影响大于脱乙酰度对其的影响.超声波导致了壳聚糖分子量的降低和产物晶体结构的破坏,但没有改变产物的脱乙酰度和糖残基结构.     

O-羧甲基壳聚糖纳米微粒制备及对Ni~(2+)吸附研究

将壳聚糖与氯乙酸反应,通过控制反应条件制备了取代度为0.71的O-羧甲基壳聚糖,将改性后的O-羧甲基壳聚糖与多聚磷酸钠反应,制备了粒径分布在370-710nm的O-羧甲基壳聚糖纳米微粒,透射电镜观察表明该微粒呈球状,平均粒径为450nm.在此基础上研究了O-羧甲基壳聚糖纳米微粒对工业电镀镍废水Ni~(2+)吸附性能,考察了溶液pH、Ni~(2+)起始浓度、平衡吸附时间、粒径等因素的影响,结果表明:O-羧甲基壳聚糖微粒最佳吸附条件是Ni~(2+)溶液pH为8.0、Ni~(2+)溶液起始浓度为33.28mg/ml、平衡吸附时间为0.5h、粒径较小的O-羧甲基壳聚糖纳米微粒对Ni~(2+)的吸附量要大于粒径较大的吸附量.     

肽类药物口服剂型材料及控制释放性能研究：Ⅰ.壳聚糖—海藻酸盐？…

应用壳聚糖－海藻酸盐微囊技术制备了一系列胰岛素微型,并研究了不同反应条件如海藻酸钠浓度,壳聚糖浓度,壳聚糖分子量及壳聚糖溶液ｐＨ值对生囊的胰岛素包封率及其释放性能的影响。结果表明,海藻酸钠浓度越高,微囊对胰岛素的包封率越高,在模拟小肠液中释放速度越低;壳聚糖浓度越大,微囊的胰岛素包封率及其在模拟胃液中释放率越高,在模拟肠液中释放达最大值所需时间越长;而随壳聚糖分子量减小,微囊在胃液中释放率增高;壳     

庚醛改性壳聚糖的制备及其对酚类化合物的吸附性能

在相转移催化剂存在下由庚醛与壳聚糖反应生成Schiff's碱,再用NaBH4 还原制备了N-烷基化壳聚糖衍生物,改性壳聚糖(CTS)产物的结构用FTIR和XRD进行了表征,研究了它对2,4-二氯酚的吸附性能. 考察了吸附时间、溶液pH值、2,4-二氯酚浓度和改性剂用量等因素对吸附的影响. 结果表明,改性CTS具有较好的抗酸碱性能;溶液的pH值对吸附的影响较大,在pH=6.0,吸附2 h时对2,4-二氯酚的吸附量最大,酚浓度对吸附的影响符合Freundlich吸附等温方程;改性壳聚糖对2,4-二氯酚的吸附性能明显优于未改性的CTS,对质量浓度为0.6 g/L的2,4-二氯酚溶液的吸附量分别为70.0和7.7 mg/g.     

海藻酸钠-壳聚糖-粉末活性炭生物微胶囊的传递性能研究

测定不同分子量的聚乙二醇(PEG)溶液透过海藻酸钠-壳聚糖-粉末活性炭(SA-CA-PAC)生物微胶囊的性能,确定了SA-CA-PAC膜的截留分子量在PEG4000以下。研究了葡萄糖、乳糖、氨基酸等小分子的物质在SA-CA-PAC微胶囊中的扩散性能,用数学模型计算出了这些物质在微胶囊的混合扩散系数Dm以及相应的微胶囊膜层中扩散系数D1,结果表明小分子量的物质具有较好的扩散性能,且Dl<相似文献   

Quantitative characterization of membrane formation process of alginate–chitosan microcapsules by GPC

The semi-permeable membrane of alginate–chitosan (AC) microcapsules has been proven important to control the microcapsule stability and selective substance diffusion rate. Therefore, a novel and operable methodology based on gel permeation chromatography (GPC) was established for quantitative characterization of the membrane formation process, so as to provide guidance on performance improvement of AC microcapsules in biomedical applications. Not only the molecular weight (M_w) and its distribution of chitosan can be obtained by GPC, but also the area integral of molecular weight peaks can be linearly correlated to chitosan concentration in certain range. The dynamic membrane formation process was then obtained by quantitatively analyzing reaction amount of chitosan with time, which showed that for chitosan molecules with wide M_w distribution, only parts of molecules bind with alginate to form microcapsule membrane. Moreover, the contribution of chitosan molecules participating in the membrane formation process was also different. These new findings, therefore, are helpful for adjusting and controlling the membrane formation process and properties of microcapsule membrane.     

Degradation of PEG and non-PEG alginate-chitosan microcapsules in different pH environments

Bioencapsulation allows the protection of biologically active substances or cells from the biological environment. As such, bioencapsulation is often used for the delivery of drugs, growth factors and therapeutically useful cells. Depending on the site of implantation, the biocapsules are subjected to different pH environments, which will affect the degradation properties, mechanical properties and swelling behaviour of the biocapsules. As such, the encapsulation material plays an important role in the long term stability and performance of the biocapsules in vivo. In this study, five types of encapsulation materials were investigated: (i) alginate (A), (ii) alginate-chitosan (AC), (iii) alginate-chitosan-alginate (ACA), (iv) alginate-chitosan-polyethylene glycol (PEG) (ACP) and (v) alginate-chitosan-polyethylene glycol (PEG)-alginate (ACPA). Degradation studies were carried out by immersing the microcapsules in solutions of different pH values to investigate the role of the material as well as the number of encapsulation layers in maintaining the stability of the microcapsules in the different pH environments. Compression testing indicated that even with the presence of PEG on the surface membrane, there was not much difference in mechanical strength between ACA and ACPA microcapsules. However, the use of PEG did affect the weight change of the ACPA microcapsules when immersed in water and three different pH solutions. For the swelling test, the ACPA microcapsules showed a lower water uptake than ACA microcapsules. For degradation, the presence of PEG led to a lower increase in weight change compared to non-PEG chitosan microcapsules. Hence, the study revealed that PEG influenced the integrity of the surface membrane and not the mechanical strength of the microcapsules. With the inclusion of PEG, the interpenetrating network on the surface membrane would be further reinforced. As such, the addition of PEG to the alginate-chitosan microcapsules led to protection against an acidic environment, whilst the number of coating layers only influences the swelling properties and not the degradation and Young’s modulus of the microcapsules.     

Synthesis and Spectrophotometric Analysis of Microcapsules Containing Immortelle Essential Oil

In this study, microcapsules were prepared by solvent evaporation technique using ethyl cellulose component as wall and essential oil as core material. The synthesis of microcapsules was carried out using different oil masses. The analysis of the microcapsules was carried out using field emission scanning electron microscope (FE-SEM) and UV spectrophotometric analysis using absorption spectrophotometer. The obtained results confirm the regular spherical shape and size of the synthesized microcapsules. The qualitative and quantitative spectrophotometric analysis of the microencapsulated immortelle oil was measured at the wavelength of 265 nm. The calibration diagram was used to calculate the unknown concentrations of the microencapsulated oil. The obtained results confirm the application of the presented method as relevant for the possible determination of microencapsulated oil on textile materials.     

Tramadol Release from a Delivery System Based on Alginate‐Chitosan Microcapsules

Alginate‐chitosan microcapsules to control the release of Tramadol‐HCl were prepared using two different methods. In the two‐stage procedure (Variant I) alginate was first pumped into a CaCl₂/NaCl solution and then transferred into a chitosan solution. In the one‐stage procedure (Variant II) alginate was directly pumped into a chitosan/CaCl₂ solution, and different behavior could be noted in each case. The microcapsules were spherical in both variants and they swelled to a greater extent in a basic medium as compared to an acid one. The drug release profile of Tramadol from microcapsules in simulated gastric fluid and simulated intestinal fluid was also studied. The maximum release of Tramadol at 24 h was 64% and 86% for Variant I and II, respectively, in simulated intestinal fluid. Release was adjusted using the power law of the semi‐empirical Peppas equation in order to gain information about the release mechanism. In both cases the values of the exponent were found to be between 0.53 and 0.84 for swellable microcapsules in simulated gastric and intestinal fluids, respectively, indicating anomalous drug transport for both variants. The good results obtained with alginate‐chitosan microcapsules are comparable to those of the best products so far described in the scientific bibliography and in addition, chitosan is useful in pharmacy.

Surface morphology of Tramadol‐loaded microcapsule.     

Preparation and characterization of chitosan/gelatin microcapsules containing triclosan

Chitosan/gelatin (C/G) microcapsules containing triclosan were prepared by a spray drying method. The core material, triclosan (TS) dissolved in octyl salicylate (OS), were emulsified in an aqueous solution containing variable ratios of chitosan/gelatin. The microcapsules were obtained by spray-drying the emulsions. On the scanning electron micrographs, the microcapsules were spherical and exhibited a core and shell morphology. The thermograms of the microcapsules showed no evidence for the melting of TS, suggesting that TS remained dissolved in the cores of the microcapsules and did not exist as a solid crystalline even after dry microcapsules were formed. According to the results of microelectrophoresis study, the point of zero charge of the microcapsules occurred around pH 9.0 and a higher content of chitosan in the microcapsule wall resulted in a higher positive charge of zeta potential. The degree of release of TS and OS from the C/G microcapsules in an aqueous solution of hydroxypropyl-beta-cyclodextrin (HP-beta-CD) was investigated. When chitosan is included in the wall of microcapsules, the degree of release was suppressed. This indicates that chitosan forms a more compact wall than gelatin. On the other hand, TS was released much more than OS. The preferred release of TS is probably due to the higher solubility of TS in the HP-beta-CD solution.     

Microencapsulation of DNA Within alginate microspheres and crosslinked chitosan membranes for in vivo application

Calf thymus DNA was microencapsulated within crosslinked chitosan membranes, or immobilized within chitosan-coated alginate microspheres. Microcapsules were prepared by interfacial polymerization of chitosan, and alginate microspheres formed by emulsification/ internal gelation. Diameters ranged from 20 to 500 Μm, depending on the formulation conditions. Encapsulated DNA was quantifiedin situ by direct spectrophotometry (260 nm) and ethidium bromide fluorimetry, and compared to DNA measurements on the fractions following disruption and dissolution of the microspheres. Approximately 84% of the DNA was released upon core dissolution and membrane disruption, with 12% membrane bound. The yield of encapsulation was 96%. Leakage of DNA from intact microspheres/capsules was not observed. DNA microcapsules and microspheres were recovered intact from rat feces following gavage and gastrointestinal transit. Higher recoveries (60%) and reduced shrinkage during transit were obtained with the alginate microspheres. DNA was recovered and purified from the microcapsules and microspheres by chromatography and differential precipitation with ethanol. This is the first report of microcapsules or microspheres containing biologically active material (DNA) being passed through the gastrointestinal tract, with the potential for substantial recovery.     

微囊化海藻酸离子移变凝胶的制备、结构与性能

通过静电脉冲技术制备了海藻酸-壳聚糖-海藻酸(Alginate-Chitosan-Alginate,ACA)微胶囊,红外光谱分析表明,ACA是一种以聚电解质配合物为囊膜,以海藻酸钠离子吸附剂为囊心物的微胶囊型离子吸附体系.扫描电镜测试表明,ACA吸附重金属离子的过程是微胶囊囊内海藻酸凝胶化的过程,其解吸附过程是海藻酸凝胶转变成海藻酸溶液的过程.与传统离子交换树脂相比,ACA对Pb²⁺的吸附具有较高的去除率、很强的富集能力和较低的极限吸附浓度,并且能够被多次重复使用.ACA的离子交换速率比传统离子交换树脂快得多,离子交换过程中,交换离子和吸附剂海藻酸分子的相互扩散大大提高了离子交换速率.     

pH值对正十八烷微胶囊合成与性能的影响

pH值对正十八烷微胶囊合成与性能的影响;微胶囊;相变材料;正十八烷     

载细胞海藻酸钠/壳聚糖微胶囊的化学破囊方法研究

以海藻酸钠-壳聚糖-海藻酸钠微胶囊(简称ACA微胶囊)为研究体系,建立了一种生理条件下ACA微胶囊的化学破囊方法,破囊过程充分考虑了对囊内生物物质活性的保持.以微生物细胞PichiapastorisGS115和动物细胞L929为模型,以NaHCO₃和Na₃C₆H5O₇·2H₂O为破囊液基本组分,考察了破囊液对ACA微胶囊的破囊效果及破囊过程对囊内细胞活性的影响.结果表明,破囊操作可在30s内完成,破囊率为100%,微胶囊膜完全溶解,破囊后细胞存活率在85%以上.